Two Sigma Investments, LP Sage Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 161,796 shares of SAGE stock, worth $854,282. This represents 0.0% of its overall portfolio holdings.

Number of Shares

161,796

Previous 212,861 23.99%

Holding current value

$854,282

Previous $2.31 Million 49.55%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.02 - $13.08 $358,476 - $667,930	-51,065 Reduced 23.99%	161,796 $1.17 Million
Q2 2024 Aug 14, 2024	SELL	$10.58 - $17.9 $1.23 Million - $2.08 Million	-115,986 Reduced 35.27%	212,861 $2.31 Million
Q1 2024 May 15, 2024	BUY	$18.62 - $26.95 $1.49 Million - $2.15 Million	79,875 Added 32.08%	328,847 $6.16 Million
Q4 2023 Feb 14, 2024	BUY	$17.1 - $22.26 $4.26 Million - $5.54 Million	248,972 New	248,972 $5.4 Million
Q2 2023 Aug 14, 2023	SELL	$40.65 - $59.54 $1.72 Million - $2.52 Million	-42,251 Reduced 89.74%	4,832 $227,000
Q1 2023 May 15, 2023	BUY	$37.27 - $46.57 $752,481 - $940,248	20,190 Added 75.08%	47,083 $1.98 Million
Q4 2022 Feb 14, 2023	SELL	$32.2 - $43.61 $3.54 Million - $4.8 Million	-109,960 Reduced 80.35%	26,893 $1.03 Million
Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $1.26 Million - $1.69 Million	-39,172 Reduced 22.25%	136,853 $5.36 Million
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $4.67 Million - $6.45 Million	169,706 Added 2685.65%	176,025 $5.69 Million
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $194,056 - $288,841	6,319 New	6,319 $209,000
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $8.28 Million - $12 Million	-150,794 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $1.36 Million - $1.87 Million	19,301 Added 14.68%	150,794 $11.3 Million
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $3.41 Million - $5.21 Million	58,449 Added 80.02%	131,493 $11.4 Million
Q3 2020 Nov 16, 2020	SELL	$41.13 - $62.45 $12.5 Million - $19 Million	-304,235 Reduced 80.64%	73,044 $4.46 Million
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $2.64 Million - $4.39 Million	-101,746 Reduced 21.24%	377,279 $15.7 Million
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $12.2 Million - $36.1 Million	467,722 Added 4138.03%	479,025 $13.8 Million
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $680,214 - $1.75 Million	11,303 New	11,303 $816,000
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $5.5 Million - $15.2 Million	-90,596 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $5.56 Million - $8.02 Million	90,596	90,596 $5.64 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $314M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Sage Therapeutics, Inc. Transaction History